TerminatedNCT01220297
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT
PHASE2 · 3 planned enrolment
- Countries listed
- 1
- Registry update
- June 5, 2017
immortal.lifeTrial registrations containing the exact intervention label Mycophenolate mofetil (MMF).
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 3 planned enrolment